Provided by Tiger Trade Technology Pte. Ltd.

Alger Mid Cap 40 ETF

23.47
+0.51002.22%
Post-market: 23.470.00000.00%19:30 EDT
Volume:16.93K
Turnover:395.73K
Market Cap:154.90M
PE:- -
High:23.55
Open:22.93
Low:22.93
Close:22.96
52wk High:24.82
52wk Low:18.46
Shares:6.60M
Float Shares:6.60M
Volume Ratio:0.81
T/O Rate:0.26%
Dividend:0.04
Dividend Rate:0.18%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Mesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches

TIPRANKS
·
Sep 24

AI Daily: Shopify, Affirm slide as Muse checkout image sparks concerns

TIPRANKS
·
Sep 24

Micron (MU) vs. AMD: Wall Street Sees 40%+ Upside in This AI Chip Stock

TIPRANKS
·
Sep 23

AI Daily: Meta’s Muse seen becoming most used AI app since ChatGPT

TIPRANKS
·
Sep 23

‘Not What You Think Anymore,’ Says Investor About Sandisk Stock

TIPRANKS
·
Sep 22

AMD vs. Oracle: One AI Stock Has Room to Run, the Other’s Upside is Capped, Says Investor

TIPRANKS
·
Sep 21

Ultragenyx price target raised to $35 from $32 at Barclays

TIPRANKS
·
Sep 21

Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide

TIPRANKS
·
Sep 19

AI Daily: CA Governor issues executive order to advance ‘AI kill switch’

TIPRANKS
·
Sep 19

Freight Technologies launches AI-powered proof-of-delivery validation

TIPRANKS
·
Sep 18

Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111

TIPRANKS
·
Sep 18

中国工业迈向5.0时代:预计未来十年迎来12万亿美元投资浪潮

Deep News
·
Sep 18

XMax signs letter of cooperation with Korean fashion group for AI models

TIPRANKS
·
Sep 18

Ultragenyx confirms FDA approval of Fayuvi

TIPRANKS
·
Sep 18

AI Daily: OpenAI, Anthropic staff ‘blindsided’ by call to slow AI

TIPRANKS
·
Sep 18

‘It Can Be Done,’ Says Top Investor About Microsoft Stock

TIPRANKS
·
Sep 17

EVA DEFENSE UNVEILS NEXT-GENERATION LOW-NOISE AUTONOMOUS DRONE PROTOTYPE DESIGNED FOR STEALTH-ORIENTED OPERATIONS

GlobeNewswire
·
Sep 17

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

TIPRANKS
·
Sep 17

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

TIPRANKS
·
Sep 17

C3.ai Faces Renewed Dismissal Bid as Defendants Attack Securities Fraud Claims Over CEO’s Health Disclosures

TIPRANKS
·
Sep 17